TMCI Investors Have Final Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - A class action lawsuit has been filed against Treace Medical Concepts, Inc. for alleged violations of securities laws, specifically related to misleading statements about the company's performance and competition affecting its products [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Treace's securities between May 8, 2023, and May 7, 2024, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Company Performance - Treace Medical Concepts faced competition that negatively impacted its Lapiplasty 3D Bunion Correction System, leading to a decline in revenue [4]. - The company felt compelled to accelerate plans to offer an alternative osteotomy solution due to these challenges [4]. - Public statements made by Treace during the class period were deemed false and materially misleading, resulting in investor damages when the truth was revealed [4].